Page last updated: 2024-11-10

5'-methoxyhydnocarpin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5'-methoxyhydnocarpin: a multidrug pump inhibitor; isolated from Berberis plants; 5'-methoxyhydnocarpin-D is isomer of 5'-methoxyhydnocarpin; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
BerberisgenusA plant genus in the family BERBERIDACEAE. The common names of Barberry or Oregon Grape are also used for MAHONIA. The similar-named Bayberry is the unrelated MYRICA. Oregon Grape was classified by Pursh as a Berberis but Nuttall claimed it is different enough to call it a new genus, MAHONIA. Botanists insist on this name while horticulturists stay with Mahonia. They are shrubs with yellow wood and usually three-branched spines at the base of leafstalks. Flowers are yellow, six-petaled and fruit is a berry with one to several seeds. Members contain BERBERINE.[MeSH]BerberidaceaeThe Barberry plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. The shrubs have spiny leaves.[MeSH]

Cross-References

ID SourceID
PubMed CID5281879
CHEMBL ID328060
MeSH IDM0359243

Synonyms (10)

Synonym
CHEMBL328060 ,
5'-methoxyhydnocarpin d
C11162 ,
5'-methoxyhydnocarpin
5,7-dihydroxy-2-[(2r,3r)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-5-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl]chromen-4-one
AC1NQZ8C ,
5,7-dihydroxy-2-[(2r,3r)-2-(4-hydroxy-3-methoxy-phenyl)-3-(hydroxymethyl)-5-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl]chromen-4-one
54431-77-5
Q15410213
DTXSID601045530
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID398500Cytotoxicity against human SF268 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398503Cytotoxicity against human DU145 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398508Antimicrobial activity against Enterobacter cloacae2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398512Antimicrobial activity against Staphylococcus aureus2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398501Cytotoxicity against human NCI-H460 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398502Cytotoxicity against human KM20L2 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398498Cytotoxicity against human BxPC3 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398504Antimicrobial activity against Neisseria gonorrhoeae2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398510Antimicrobial activity against Candida albicans2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398507Antimicrobial activity against Micrococcus luteus2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398499Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398505Antimicrobial activity against Escherichia coli2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398509Antimicrobial activity against Cryptococcus neoformans2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398506Antimicrobial activity against Streptococcus pneumoniae2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID398497Cytotoxicity against mouse P388 cells after 48 hrs by SRB assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
AID201240Minimum inhibitory concentration, that inhibits growth of Staphylococcus aureus in the presence of subinhibitory (30 ug/mL) Berberine2001Journal of medicinal chemistry, Jan-18, Volume: 44, Issue:2
Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships.
AID377192Inhibition of Staphylococcus aureus NorA MDR efflux pump2000Journal of natural products, Aug, Volume: 63, Issue:8
Synthesis and structures of regioisomeric hydnocarpin-type flavonolignans.
AID398511Antimicrobial activity against Stenotrophomonas maltophilia2003Journal of natural products, Feb, Volume: 66, Issue:2
Isolation and structure of palstatin from the Amazon tree Hymeneae palustris(1).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (80.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.07 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]